The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a leading global professional society dedicated to advancing health economics and outcomes research (HEOR) to improve healthcare decision-making worldwide. Established in 1995, ISPOR serves as a catalyst for innovation in HEOR, providing a platform for professionals to collaborate, share research, and promote best practices. (ispor.org)
Core Functions of ISPOR
ISPOR’s primary responsibilities include:
- Advancing HEOR Excellence: Promoting the development and application of HEOR methodologies to enhance healthcare decisions globally. (ispor.org)
- Facilitating Global Collaboration: Providing forums for stakeholders across academia, industry, and government to collaborate on HEOR initiatives.
- Disseminating Research and Best Practices: Publishing peer-reviewed journals, such as Value in Health, and developing good practices reports to guide HEOR standards. (ispor.org)
Leadership and Key Contacts
As of January 2025, ISPOR is led by President Dr. Eberechukwu Onukwugha, who oversees the organization’s strategic initiatives and operations.
Contact Details for ISPOR
Website: https://www.ispor.org/
Address:
ISPOR
505 Lawrence Square Boulevard South
Lawrenceville, NJ 08648, USA
Telephone: +1 609-586-4981
Challenges in Engaging with ISPOR
Engaging with ISPOR involves:
- Understanding HEOR Methodologies: Familiarity with the latest HEOR research and methodologies is crucial for effective participation.
- Active Participation in Conferences and Events: Involvement in ISPOR’s conferences and educational events provides opportunities for networking and staying abreast of industry trends.
- Contribution to Publications and Reports: Submitting research to ISPOR’s journals and contributing to good practices reports can enhance professional recognition and impact.
Successful collaboration with ISPOR can lead to valuable partnerships and advancements in HEOR practices.
Opportunities / Solutions with Justin Stindt Consultants
Justin Stindt ISPOR expertise ensures:
- Expert Consultant ISPOR Engagement: Guiding clients in effectively engaging with ISPOR’s initiatives and leveraging its resources.
- Market Access ISPOR Strategies: Developing strategies that align with ISPOR’s HEOR standards to optimize market access.
- Specialist ISPOR Processes: Providing insights into ISPOR’s processes to enhance participation and contribution. ISPOR publications including posters and articles in ISPOR journals.
- ISPOR Consultants Support: Our team provides expert guidance on how to engage with ISPOR and maximize its potential for market access success.
Justin Stindt Consultants specializes in helping clients navigate ISPOR’s offerings to maximize their impact in the HEOR community.
Case Studies
A Healthcare Organization’s Success with ISPOR
Challenge:
A healthcare organization sought our assistance to enhance its presence in the HEOR community.
Solution:
We guided them in developing research aligned with ISPOR’s standards and facilitated their participation in ISPOR conferences.
Outcome:
Our strategic approach led to increased recognition and collaboration opportunities within the HEOR field.
Need support with ISPOR market access? Justin Stindt Consultants has the expertise to help you succeed.
Other Key Institutions in Market Access
Global Institutions
- World Health Organization (WHO)
- International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
United States
- Centers for Medicare & Medicaid Services (CMS)
- Academy of Managed Care Pharmacy (AMCP)
- Institute for Clinical and Economic Review (ICER)
France
Germany
- Gemeinsamer Bundesausschuss (G-BA)
- Institute for Quality and Efficiency in Health Care (IQWiG)
- GKV Spitzenverband
United-Kingdom
- National Institute for Health and Care Excellence (NICE)
- Scottish Medicines Consortium (SMC)
- All Wales Medicines Strategy Group (AWMSG)
- National Health Service (NHS)
Italy
Spain
- Spanish Agency of Medicines and Medical Devices (AEMPS)
- Dirección General de Cartera Común de Servicios del Sistema Nacional de Salud y Farmacia (DGCF)
- Interministerial Commission on Medicine Prices (CIPM)